Literature DB >> 1701348

Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.

K M Mulder1, Q Zhong, H G Choi, L E Humphrey, M G Brattain.   

Abstract

Previously, we reported that exponentially proliferating cultures of well-differentiated human colon carcinoma cells responded to transforming growth factor beta 1 (TGF-beta) with growth inhibition, alterations in morphology, and increased secretion of the differentiation marker, carcinoembryonic antigen. Poorly differentiated cultures were unresponsive. Here we show that TGF-beta was ineffective in repressing nutrient-stimulated mitogenesis in quiescent, poorly differentiated cells. However, in quiescent, well-differentiated cells, TGF-beta repressed the mitogenic responses to both nutrients alone (by 90%) and to nutrients plus the exogenous stimulatory factors epidermal growth factor (E), insulin (I), and transferrin (T) (by 55-65%). Thymidine incorporation experiments indicated that TGF-beta reduced both the onset and peak mitogenic response to growth factors and/or nutrients in the well-differentiated cells. Additionally, TGF-beta repressed the growth factor (E + I + T)-stimulated upregulation of expression of both c-myc and of transforming growth factor alpha (TGF-alpha) mRNAs in quiescent, well-differentiated cells. TGF-beta also elicited a rapid (t1/2 approximately 1h) down-regulation of c-myc expression in the absence of prior growth factor (E + I + T) stimulation. In contrast, TGF-beta had no effect on c-myc or TGF-alpha mRNA expression in the poorly differentiated cells. The results suggest that TGF-beta exerts rapid inhibitory effects on proliferation-associated genes in quiescent and restimulated, well-differentiated cells. Expression of these genes (c-myc and TGF-alpha) may otherwise (in the absence of TGF-beta) play roles in the cellular signaling of mitogenic responses by growth stimulatory factors in well-differentiated colon carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

Authors:  S Zhou; P Buckhaults; L Zawel; F Bunz; G Riggins; J L Dai; S E Kern; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

3.  Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.

Authors:  E Santoni-Rugiu; M R Jensen; V M Factor; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1.

Authors:  B Jahn; J Brieger; K Fenchel; P S Mitrou; L Bergmann
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

5.  Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line.

Authors:  A Okamoto; W Jiang; S J Kim; E A Spillare; G D Stoner; I B Weinstein; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Growth regulation of rabbit gastric epithelial cells and protooncogene expression.

Authors:  K Yoshiura; S Ota; A Terano; M Takahashi; Y Hata; T Kawabe; H Mutoh; H Hiraishi; R Nakata; K Okano
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

7.  The role of growth regulatory aberrations in progression of human colon carcinoma.

Authors:  G M Howell; L Sun; B L Ziober; S P Wu; M G Brattain
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

8.  Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas.

Authors:  J L Van Laethem; A Resibois; M Adler; M O Peny; H Ohtani; P Robberecht
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

9.  Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.

Authors:  S L MacKay; T Auffenberg; C L Tannahill; R Ksontini; M D Josephs; M Nowak; L L Moldawer; E M Copeland
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.

Authors:  S L MacKay; L R Yaswen; R W Tarnuzzer; L L Moldawer; K I Bland; E M Copeland; G S Schultz
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.